Beazley PLC

Declaration of Voting Results & Voting Rights Announcements • Jul 1, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0105E

Beazley PLC

01 July 2019

Beazley plc

London, 1 July 2019

Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rules, Beazley plc confirms that, as at the close of business on 28 June 2019, its issued ordinary share capital consisted of 529,161,290 shares of 5p each.

Accordingly, the total number of voting rights in the Company as at 28 June 2019 was 529,161,290.

This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Rules.

For further information please contact:

Beazley plc

Christine Oldridge

+44 (0)20 7674 7758

Note to editors:

Beazley plc (BEZ.L) is the parent company of specialist insurance businesses with operations in Europe, United States, Canada, Latin America and Asia. Beazley manages seven Lloyd's syndicates and, in 2018, underwrote gross premiums worldwide of $2,615.3 million. All Lloyd's syndicates are rated A by A.M. Best. 

Beazley's underwriters in the United States focus on writing a range of specialist insurance products. In the admitted market, coverage is provided by Beazley Insurance Company, Inc., an A.M. Best A rated carrier licensed in all 50 states. In the surplus lines market, coverage is provided by the Beazley syndicates at Lloyd's.

Beazley is a market leader in many of its chosen lines, which include professional indemnity, cyber, property, marine, reinsurance, accident and life, and political risks and contingency business.

For more information please go to: www.beazley.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRRBMLTMBTMMIL